Shengping HOU | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Shengping HOU | Medicine and Dentistry | Best Researcher Award

Director of Beijing Institute of Ophthalmology at Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, China

Dr. Shengping Hou is a prominent figure in ophthalmology, currently serving as a Professor and Director at the Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Capital Medical University. With extensive experience in ocular immunology and stem cell biology, he has contributed significantly to advancing research in vision science. His leadership roles and numerous research grants highlight his dedication to developing innovative solutions for ocular diseases. Dr. Hou has delivered invited lectures at international conferences and is actively engaged in professional service, serving as an ad hoc reviewer for esteemed journals. His work has earned him several prestigious awards, including national recognition for his achievements in science and technology.

Professional Profile

Education

Dr. Hou earned his Ph.D. in Ocular Immunology from Sun Yat-sen University, China, in 2009, showcasing his foundation in understanding immune-related ocular diseases. He further honed his expertise as a postdoctoral fellow in Ocular Stem Cell Biology at the University of California, San Francisco, in 2016. This educational background has equipped him with cutting-edge knowledge and skills, enabling him to explore and address complex issues in ophthalmology.

Professional Experience

Dr. Hou began his career as an Associate Professor at Chongqing Medical University (2009–2015), where he played a key role in ophthalmology research at the Chongqing Key Laboratory of Ophthalmology. In 2015, he was promoted to Professor, continuing his impactful work at the same institution until 2023. Currently, Dr. Hou serves as the Director at the Beijing Institute of Ophthalmology, where he leads advanced research initiatives and oversees clinical operations.

Research Interests

Dr. Hou’s research interests focus on ocular immunology, ocular stem cell biology, and the genetic basis of ocular diseases. His work delves into understanding the molecular and genetic mechanisms underlying conditions such as VKH syndrome and Behçet’s disease, with the aim of developing innovative treatments. His commitment to translating basic research into clinical solutions highlights his dedication to improving patient outcomes in ophthalmology.

Research Skills

Dr. Hou possesses advanced expertise in genetic and molecular studies, including gene editing and analysis of copy number variants. His skills also encompass stem cell culture techniques, immunological assays, and bioinformatics tools for studying ocular diseases. Additionally, his experience in securing and leading research grants demonstrates his strategic planning and leadership abilities in scientific endeavors.

Awards and Honors

Dr. Hou has received numerous awards for his contributions to ophthalmology and scientific research. These include the First Prize for the Achievement in Science and Technology from Chongqing (2010, 2015) and the Chinese Health Ministry (2012). In 2018, he was awarded the Second Prize for Scientific and Technological Progress of China, reflecting the national recognition of his impactful work. His accolades underscore his commitment to advancing knowledge in vision science and his leadership in the field.

Conclusion

Dr. Shengping Hou is a highly accomplished researcher with significant contributions to ocular immunology and stem cell biology. His academic leadership, research funding success, and national awards make him a strong candidate for the Best Researcher Award. However, further emphasis on international collaboration, impactful publications, and translational innovations could make his candidature even more competitive. Overall, Dr. Hou’s accomplishments and leadership in ophthalmology research align well with the criteria for this prestigious award.

Publication Top Notes

  1. Ocular immune-related diseases: molecular mechanisms and therapy”
    • Authors: Wang, Y.; Gao, S.; Cao, F.; Lei, F.; Hou, S.
    • Year: 2024
  2. “m6A-methylase METTL3 promotes retinal angiogenesis through modulation of metabolic reprogramming in RPE cells”
    • Authors: Zhou, Q.; Liu, X.; Lu, H.; Yang, P.; Hou, S.
    • Year: 2024
  3. “A novel metric of autoimmune disease burden and its estimated incidence across different stages in the life cycle of women”
    • Authors: Cao, F.; Pan, H.-F.; Hou, S.
    • Year: 2024
  4. “A feedback loop driven by H3K9 lactylation and HDAC2 in endothelial cells regulates VEGF-induced angiogenesis”
    • Authors: Fan, W.; Zeng, S.; Wang, X.; Li, N.; Hou, S.
    • Year: 2024
    • Citations: 3
  5. “Transcription factor EGR2 alleviates autoimmune uveitis via activation of GDF15 to modulate the retinal microglial phenotype”
    • Authors: Li, W.; He, S.; Tan, J.; Yang, P.; Hou, S.
    • Year: 2024
    • Citations: 2
  6. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X.; Wang, G.; Li, N.; Zhou, Q.; Hou, S.
    • Year: 2024
    • Citations: 1
  7. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X.; Zhou, Q.; Meng, J.; Mao, L.; Hou, S.
    • Year: 2024
    • Citations: 1
  8. “Polyvinylpyrrolidone-curcumin nanoparticles with immune regulatory and metabolism regulatory effects for the treatment of experimental autoimmune uveitis”
    • Authors: Cao, F.; Liang, K.; Tang, W.-W.; Tao, L.-M.; Wang, X.
    • Year: 2024
    • Citations: 6
  9. “Trends and cross-country inequalities in the global burden of osteoarthritis, 1990–2019: A population-based study”
    • Authors: Cao, F.; Xu, Z.; Li, X.-X.; Hou, S.; Pan, H.-F.
    • Year: 2024
    • Citations: 14
  10. “YY1 Lactylation Aggravates Autoimmune Uveitis by Enhancing Microglial Functions via Inflammatory Genes”
    • Authors: Huang, J.; Wang, X.; Li, N.; Yang, P.; Hou, S.
    • Year: 2024
    • Citations: 9

 

Ting-Ting Chang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Ting-Ting Chang l Medicine and Dentistry l Best Researcher Award

Associate Professor at National Yang Ming Chiao Tung University, Taiwan

Dr. Ting-Ting Chang is an Associate Professor at National Yang Ming Chiao Tung University, specializing in vascular medicine, kidney disease, diabetes, and new drug development. With a Ph.D. from National Yang-Ming University, Dr. Chang has a robust publication record in high-impact journals, including Science Translational Medicine and Angiogenesis. Recognized with awards such as the Young Scientists Award and the Young Investigator Fellowship, Dr. Chang is also a full member of Sigma Xi and other prestigious societies. Their research is notable for its innovation and significant contributions to understanding and treating complex diseases.

Profile:

Education

Ting-Ting Chang, Ph.D., earned her Ph.D. in Pharmacology from National Yang-Ming University in Taipei, Taiwan, in 2015. Her educational journey is distinguished by her continued academic and research excellence, which laid a strong foundation for her current role as an Associate Professor in the Department and Institute of Pharmacology at National Yang Ming Chiao Tung University. Prior to this, Dr. Chang completed her post-doctoral research at the same institution, further solidifying her expertise in pharmacology and related fields.

Professional Experience

Ting-Ting Chang, Ph.D., is an accomplished researcher and academic with extensive experience in the field of pharmacology. Currently serving as an Associate Professor at the Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Dr. Chang has previously held roles as an Assistant Professor and Post-doctoral Researcher at the same institution. Their career spans significant contributions to vascular medicine, kidney disease, diabetes, and new drug development, with a track record of high-impact research and numerous publications in leading scientific journals.

Research Interest

Ting-Ting Chang’s research interests encompass a broad range of topics within vascular medicine and molecular biology, focusing on the mechanisms underlying vascular dysfunction, kidney disease, and diabetes mellitus. Her work includes experimental animal model design and new drug development, aiming to uncover novel therapeutic targets and strategies for these critical health issues. Dr. Chang’s research integrates molecular and cellular approaches to address complex pathological conditions, contributing significantly to advancements in understanding and treating vascular and metabolic disorders.

Research Skills

Ting-Ting Chang, Ph.D., demonstrates exceptional research skills through a robust portfolio of high-impact publications and significant contributions to fields such as vascular medicine, kidney disease, and diabetes. With a strong academic background and extensive experience as both an Associate Professor and Post-doctoral Researcher, Dr. Chang excels in designing and conducting innovative studies, particularly in identifying novel therapeutic targets and mechanisms. Their proficiency in experimental animal model design and new drug development further highlights their expertise, while their membership in prestigious scientific societies and receipt of notable awards underscore their recognition and influence in the research community.

Award and Recognition

Ting-Ting Chang, Ph.D., has garnered significant awards and recognition throughout their career, underscoring their outstanding contributions to research. Notably, Dr. Chang received the Young Scientists Award at the 55th Annual Scientific Meeting of the Japan Atherosclerosis Society in 2023 and the Young Investigator Fellowship Award at the 88th European Atherosclerosis Society Congress in 2020. In addition, Dr. Chang was awarded full membership of Sigma Xi in 2023, reflecting their esteemed position in the scientific community and their impactful research in vascular medicine, kidney disease, and diabetes.

Conclusion

Ting-Ting Chang, Ph.D., is a highly qualified candidate for the Best Researcher Award. Their exceptional contributions to vascular medicine, kidney disease, and diabetes, along with a strong publication record and recognition in the scientific community, underscore their suitability for this award. Addressing areas for improvement, such as expanding research applications and increasing public engagement, could further enhance their profile as a leading researcher. Overall, Dr. Chang’s dedication, innovative research, and professional achievements make them an excellent contender for the Best Researcher Award.

Publication Top Notes

  • Association between vitiligo and risk of retinal detachment: a population-based cohort study in Taiwan
    • Authors: Chen, C.-L., Wu, C.-Y., Chen, Y.-L., Chang, Y.-T., Wu, C.-Y.
    • Year: 2024
    • Citations: 0
  • Rejuvenation of the dorsal hand by injectable poly-D, L-lactic acid: A pilot study
    • Authors: Ma, S.-H., Lin, C.-Y., Lin, J.-Y., Chang, Y.-T., Chen, C.-C.
    • Year: 2024
    • Citations: 0
  • Correlation of Disease Severity, Proinflammatory Cytokines, and Reduced Brain Gray Matter Volumes in Patients with Atopic Dermatitis
    • Authors: Li, C.-Y., Chang, W.-C., Chen, M.-H., Chen, Y.-Y., Bai, Y.-M.
    • Year: 2024
    • Citations: 0
  • Risk of Type 1 Diabetes Mellitus in Patients with Atopic Dermatitis: A Nationwide Population-Based Cohort Study
    • Authors: Li, M.-C., Wu, C.-Y., Chang, Y.-T., Lyu, Y.-S., Wu, C.-Y.
    • Year: 2023
    • Citations: 0
  • Assoziation zwischen chronischer Nierenerkrankung und dem Risiko für bullöses Pemphigoid: eine nationale bevölkerungsbasierte Kohortenstudie
    • Authors: Yu, W.-T., Ma, S.-H., Wu, C.-Y., Chang, Y.-T., Wu, C.-Y.
    • Year: 2023
    • Citations: 1